These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10545794)

  • 41. Prognostic significance of autoimmunity during treatment of melanoma with interferon.
    Gogas H; Ioannovich J; Dafni U; Stavropoulou-Giokas C; Frangia K; Tsoutsos D; Panagiotou P; Polyzos A; Papadopoulos O; Stratigos A; Markopoulos C; Bafaloukos D; Pectasides D; Fountzilas G; Kirkwood JM
    N Engl J Med; 2006 Feb; 354(7):709-18. PubMed ID: 16481638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour.
    Millanta F; Fratini F; Corazza M; Castagnaro M; Zappulli V; Poli A
    Res Vet Sci; 2002 Aug; 73(1):45-51. PubMed ID: 12208106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy.
    Bettencourt MC; Bauer JJ; Sesterhenn IA; Mostofi FK; McLeod DG; Moul JW
    J Urol; 1996 Sep; 156(3):1064-8. PubMed ID: 8709308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
    Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
    Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A; Wanek LA; Morton DL
    J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma?
    Hsueh EC; Gupta RK; Yee R; Leopoldo ZC; Qi K; Morton DL
    Ann Surg Oncol; 2000 Apr; 7(3):232-8. PubMed ID: 10791855
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
    Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
    Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kinesin family member 20A is a novel melanoma-associated antigen.
    Yamashita J; Fukushima S; Jinnin M; Honda N; Makino K; Sakai K; Masuguchi S; Inoue Y; Ihn H
    Acta Derm Venereol; 2012 Nov; 92(6):593-7. PubMed ID: 22854760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Correlation between tumor cell proliferation and prognosis of primary cutaneous malignant melanoma in 127 patients].
    Wang Y; Xue WC; Si L; Cui CL; Lu AP; Cao DF; Guo J; Li ZW
    Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):178-81. PubMed ID: 23769437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Analysis for predicting the prognostic factors of gastrointestinal tract leiomyosarcoma using MIB-1 and DNA flow cytometry].
    Nishio T; Nakagomi H; Mutou S; Miyake T; Hagiwara J; Ashizawa I; Oyama T; Takano K; Tada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():475-80. PubMed ID: 9589056
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer.
    Neri A; Marrelli D; Pedrazzani C; Caruso S; De Stefano A; Mariani F; Megha T; De Marco G; Corso G; Pinto E; Roviello F
    Eur J Surg Oncol; 2008 Dec; 34(12):1299-303. PubMed ID: 18164172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel role for RGS1 in melanoma progression.
    Rangel J; Nosrati M; Leong SP; Haqq C; Miller JR; Sagebiel RW; Kashani-Sabet M
    Am J Surg Pathol; 2008 Aug; 32(8):1207-12. PubMed ID: 18580492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic impact of B-cell density in cutaneous melanoma.
    Ladányi A; Kiss J; Mohos A; Somlai B; Liszkay G; Gilde K; Fejös Z; Gaudi I; Dobos J; Tímár J
    Cancer Immunol Immunother; 2011 Dec; 60(12):1729-38. PubMed ID: 21779876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients.
    Fujimoto Y; Nakanishi Y; Yoshimura K; Shimoda T
    Gastric Cancer; 2003; 6(1):39-48. PubMed ID: 12673425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proliferation index determined by MIB-1 and recurrence in endometrial cancer.
    Geisler JP; Wiemann MC; Zhou Z; Miller GA; Geisler HE
    Gynecol Oncol; 1996 Jun; 61(3):373-7. PubMed ID: 8641618
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins.
    Amada S; Nakano H; Tsuneyoshi M
    Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
    Naffouje S; Naffouje R; Bhagwandin S; Salti GI
    Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple regression analysis for assessing the growth of small hepatocellular carcinoma: the MIB-1 labeling index is the most effective parameter.
    Saito Y; Matsuzaki Y; Doi M; Sugitani T; Chiba T; Abei M; Shoda J; Tanaka N
    J Gastroenterol; 1998 Apr; 33(2):229-35. PubMed ID: 9605954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of cytotoxic T cells as a novel independent survival factor in malignant melanoma with percutaneous peptide immunization.
    Fujiyama T; Oze I; Yagi H; Hashizume H; Matsuo K; Hino R; Kamo R; Imayama S; Hirakawa S; Ito T; Takigawa M; Tokura Y
    J Dermatol Sci; 2014 Jul; 75(1):43-8. PubMed ID: 24802712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.